Research has shown, for example, that raising glutathione may even aid conditions like fatty liver disease by reducing oxidative damage in liver cells
To further explore on- and off-label use of these drugs, Avalere Health evaluated 20182023 commercial (42% population sample), Medicare fee-for-service (FFS) (100%), Medicare Advantage (25%), and Managed Medicaid (69%) pharmacy claims data to identify beneficiaries with a pharmacy drug claim for GLP-1 and/or GIP/GLP-1 RAs
R = 0.703, p = 0.005, respectively)
Grisoni F, Neuhaus CS, Hishinuma M, Gabernet G, Hiss JA, Kotera M, Schneider G (2019) De novo design of anticancer peptides by ensemble artificial neural networks
The FDAs phrasing is not accidental
References Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, Zeuthen N, Kushner RF